Sinclair Pharma PLC (SPH) Receives Consensus Rating of “Buy” from Brokerages
Sinclair Pharma PLC (LON:SPH) has earned an average recommendation of “Buy” from the seven brokerages that are covering the firm, Marketbeat reports. One analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is GBX 54 ($0.71).
Several research firms have recently weighed in on SPH. N+1 Singer cut their target price on shares of Sinclair Pharma PLC from GBX 42 ($0.55) to GBX 37 ($0.49) and set a “buy” rating for the company in a report on Wednesday, April 19th. Peel Hunt reaffirmed a “buy” rating and set a GBX 68 ($0.90) target price on shares of Sinclair Pharma PLC in a report on Wednesday, April 12th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and set a GBX 71 ($0.94) target price on shares of Sinclair Pharma PLC in a report on Tuesday, July 11th.
ILLEGAL ACTIVITY WARNING: “Sinclair Pharma PLC (SPH) Receives Consensus Rating of “Buy” from Brokerages” was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another publication, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/08/04/sinclair-pharma-plc-sph-receives-consensus-rating-of-buy-from-brokerages.html.
Sinclair Pharma PLC (SPH) opened at 29.25 on Friday. Sinclair Pharma PLC has a 12 month low of GBX 26.00 and a 12 month high of GBX 36.35. The company’s market cap is GBX 146.89 million. The company’s 50 day moving average is GBX 30.29 and its 200-day moving average is GBX 31.89.
Sinclair Pharma PLC Company Profile
Sinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, which include its operations in France, the United Kingdom, Italy, Germany and Spain, and International Operations, under which the Company sells through a local distributor.
Receive News & Ratings for Sinclair Pharma PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinclair Pharma PLC and related companies with MarketBeat.com's FREE daily email newsletter.